Advertisement

Pharmacist Moms Group

Videos
View More
Experts: Study Shows Text Messaging Boosts Prescription Fulfillment

Ben Long, MD, and Weston Blakeslee discuss how personalized text reminders significantly improve prescription adherence in heart failure patients and the critical role pharmacists play in reinforcing engagement.

Why Unified Messaging Matters for Childhood Immunization Confidence

Jeffery A. Goad, PharmD, MPH, stresses that consistent, evidence-based communication from pharmacists and other health care professionals is essential to maintaining public trust and preventing declines in childhood vaccination.

Expert Highlights Patient-Centered Advantages of Bispecific Antibody Therapy

Zahra Mahmoudjafari explains how the epcoritamab, rituximab, and lenalidomide regimen delivers durable responses in relapsed or refractory follicular lymphoma while expanding the pharmacist’s role in dosing coordination and toxicity management.

Recognizing and Managing Breakthrough Bleeding in Hemophilia

Explore essential strategies for effective breakthrough bleeding management, emphasizing early recognition and treatment to minimize long-term joint damage.

Guiding Treatment Decisions After Tardive Dyskinesia Diagnosis

In this episode, the panel discusses how clinicians determine whether treatment for tardive dyskinesia is warranted once abnormal movements are identified.

Unmet Needs in Tardive Dyskinesia and Opportunities to Improve Early Recognition

In this episode, panelists identify early recognition of tardive dyskinesia as a significant unmet need and describe key opportunities to improve screening.

Individualizing Prophylaxis and Acute Management in Hemophilia Care

Explore effective prophylactic measures and individualized treatment options for managing hemophilia and preventing bleeding in patients.

Pharmacists Face New Challenges Under Updated HHS Vaccine Guidance

Jeffery A. Goad, PharmD, MPH, explains how the shift toward shared clinical decision-making for pediatric vaccines may complicate counseling, reduce vaccine uptake, and increase public health risks.

Epcoritamab Combination Sets New Standard in Second-Line Follicular Lymphoma Care

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, explains how the epcoritamab, rituximab, and lenalidomide regimen delivers durable responses in relapsed or refractory follicular lymphoma while expanding the pharmacist’s role in dosing coordination and toxicity management.

Advertisement
Advertisement

Official Media Partner

Official Media Partner

Official CE Partner

Official CE Partner

Founder of Women Pharmacist Day

Founder of Women Pharmacist Day
pharmacist moms group logo
Stay In Touch
an mjh life sciences brand

© 2021 MJH Life Sciences and Pharmacy Times®. All rights reserved.

Privacy Policy